News

Pharmaceutical Technology Excellence Awards are now open for submissions, and you can download our Research Guide for more ...
The French drugmaker said it would commit at least $20bn in the US through 2030, with the aim to increase R&D and ...
AbbVie has signed a collaboration and licensing agreement with US-based ADARx Pharmaceuticals, committing $335m upfront to ...
Kaerus Bioscience has received US Food and Drug Administration’s (FDA) designations for KER-0193 to treat Fragile X syndrome ...
A new specialist manufacturing facility in Scotland could soon provide solutions to scaling challenges for vital ...
Boehringer Ingelheim has entered a multi-year partnership with Tempus AI to progress its cancer treatment pipeline.
Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.
Recipharm has joined forces with ProductLife Group (PLG) to support (bio)pharmaceutical firms in expediting market approval ...